We used heavy-labeled reference peptides to measure the RPL39L-to-RPL39 protein ratio in mature mouse sperm cells as positive control, and then in mouse embryonic stem cells, the human MDA-MB-231 breast cancer cell line, as well as human tissue samples, namely bone marrow-derived mesenchymal stem cells and breast cancer tissue. The gene discussed is RPL39; the disease is breast carcinoma.